These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30643992)

  • 1. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.
    Puchner A; Gröchenig HP; Sautner J; Helmy-Bader Y; Juch H; Reinisch S; Högenauer C; Koch R; Hermann J; Studnicka-Benke A; Weger W; Puchner R; Dejaco C
    Wien Klin Wochenschr; 2019 Jan; 131(1-2):29-44. PubMed ID: 30643992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.
    Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ;
    Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)].
    Reider S; Novacek G; Haas T; Gröchenig HP; Platzer R; Koch R; Kump PK; Reinisch W; Moschen A
    Z Gastroenterol; 2023 Nov; 61(11):1518-1525. PubMed ID: 37944910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for the use of faecal microbiota transplantation "stool transplantation": consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine].
    Kump PK; Krause R; Steininger C; Gröchenig HP; Moschen A; Madl C; Novacek G; Allerberger F; Högenauer C
    Z Gastroenterol; 2014 Dec; 52(12):1485-92. PubMed ID: 25474284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)].
    Rath E; Bonelli M; Duftner C; Gruber J; Mandl P; Moazedi-Furst F; Pieringer H; Puchner R; Flick H; Salzer HJF; Weiss G; Winkler S; Skvara H; Moschen A; Hofer H; Feurstein J; Sautner J
    Z Rheumatol; 2023 Mar; 82(2):163-174. PubMed ID: 36342525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party].
    Gasche C; Evstatiev R; Haas T; Kaser A; Knoflach P; Petritsch W; Weiss G; Reinisch W
    Z Gastroenterol; 2011 May; 49(5):627-32. PubMed ID: 21526463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs).
    Rath E; Bonelli M; Duftner C; Gruber J; Mandl P; Moazedi-Furst F; Pieringer H; Puchner R; Flick H; Salzer HJF; Weiss G; Winkler S; Skvara H; Moschen A; Hofer H; Feurstein J; Sautner J
    Wien Klin Wochenschr; 2022 Nov; 134(21-22):751-765. PubMed ID: 36036323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.
    Saha S; Wald A
    Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of biologics in pregnant, lactating patients with inflammatory bowel disease and the impact on neonatal vaccination: A systematic review of clinical practice guidelines and consensus statements.
    Ding N; Zhao L; Zhu L; Sun W; Li D; Li J; Zhang J; Zhang S
    J Clin Pharm Ther; 2022 Dec; 47(12):1952-1965. PubMed ID: 36452989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    McConnell RA; Mahadevan U
    Inflamm Bowel Dis; 2016 Jan; 22(1):213-23. PubMed ID: 26444103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women.
    Guerrero Vinsard D; Kane SV
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):633-641. PubMed ID: 33440996
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-TNF therapy in inflammatory bowel diseases during pregnancy and breast-feeding].
    Persić M
    Acta Med Croatica; 2013 Apr; 67(2):157-64. PubMed ID: 24471298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biologic therapy in pregnancy: a gastroenterologist's perspective.
    Hassid B; Mahadevan U
    Curr Opin Rheumatol; 2014 May; 26(3):347-53. PubMed ID: 24625373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Novacek G; Dejaco C; Knoflach P; Moschen A; Petritsch W; Vogelsang H; Reinisch W
    Z Gastroenterol; 2014 Feb; 52(2):204-11. PubMed ID: 24488763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology].
    Novacek G; Haas T; Knoflach P; Petritsch W; Tilg H; Vogelsang H; Reinisch W
    Z Gastroenterol; 2013 Sep; 51(9):1101-9. PubMed ID: 23996653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IBD medications during pregnancy and lactation.
    Nielsen OH; Maxwell C; Hendel J
    Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):116-27. PubMed ID: 23897285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].
    Reinisch W; Dejaco C; Feichtenschlager T; Haas T; Kaser A; Miehsler W; Novacek G; Petritsch W; Platzer R; Tilg H; Vogelsang H; Knoflach P;
    Z Gastroenterol; 2011 Apr; 49(4):534-42. PubMed ID: 21442574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.
    Gisbert JP
    Inflamm Bowel Dis; 2010 May; 16(5):881-95. PubMed ID: 19885906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.